argenx

Sunrise over foggy forest in Tuscany Italy
Biotech

Versant's Dayra dawns with $50M Biogen pact

Together, Dayra and Biogen aim to discover and develop oral macrocyclic peptides for immunological diseases.
Gabrielle Masson Nov 24, 2025 10:28am
business targets illustration

Argenx's $1.5B pact to turn macrocyclic peptides to new targets

Jul 1, 2025 8:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Leo's eczema prospect hits primary endpoint in phase 2b

May 9, 2025 7:30am
target reach ladder climb meet win beat competition

J&J's phase 2 Sjögren's data support FcRn strategy

Jun 17, 2024 8:47am
graphic image of a cube with an arrow nailing the bullseye

Roivant FcRn inhibitor avoids cholesterol problem, shares spike

Sep 26, 2023 10:56am
A business window with a sign that says welcome we are open

Metrodora opens neuroimmune research center in Salt Lake City

Apr 19, 2023 11:11am